Register For Our Free Email Newsletter

Collaborations Pharmaceuticals, Inc. to partner with Washington University in St. Louis on Batten Disease

September 7, 2018

We are excited to share this research update from Collaborations Pharmaceuticals. Thank you to all those who have helped to fund the research that has made this a reality. To read more about the partnership between BDSRA and Taylor’s Tale […]

Continue Reading

BDSRA 2019 Board Nominations

August 30, 2018

The BDSRA Board of Directors has several open seats for the term beginning January 2019. If you have expertise you feel would be relevant and beneficial to the organization and are interested in learning more about serving, please contact the […]

Continue Reading

REGENXBIO Announces Pipeline Expansion with RGX-181 Gene Therapy for CLN2 Form of Batten Disease

August 30, 2018

The expansion of Batten Disease treatment options is crucial to our community‚Äôs future. We are excited to share this announcement from REGENXBIO who plans to submit an IND for a new gene therapy for CLN2 in 2019. Because of news […]

Continue Reading